Cytokinetics
CYTK
CYTK
147 hedge funds and large institutions have $658M invested in Cytokinetics in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5% more call options, than puts
Call options by funds: $11.7M | Put options by funds: $11.2M
0.61% more ownership
Funds ownership: 93.13% → 93.75% (+0.61%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
147
Holding in Top 10
3
Calls
$11.7M
Puts
$11.2M
Top Buyers
| 1 | +$40.5M | |
| 2 | +$13.6M | |
| 3 | +$13.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$7.37M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.94M |
Top Sellers
| 1 | -$38.5M | |
| 2 | -$26.4M | |
| 3 | -$12.7M | |
| 4 |
BlackRock
New York
|
-$5.13M |
| 5 |
Morgan Stanley
New York
|
-$4.77M |